Research programme: anti-infectives - NB Health Laboratory/ShionogiAlternative Names: Infectious disease therapeutics - NB Health Laboratory/Shionogi
Latest Information Update: 03 Aug 2016
At a glance
- Originator NB Health Laboratory; Shionogi
- Class Anti-infectives; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Infections